NCT07541781
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07541781
Title Sitagliptin in Recurrent/Progressive Grade 4 Glioma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kailin Yang, MD, PhD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.